{"id":"https://openalex.org/W2892010830","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","title":"Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1.","display_name":"Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2892010830","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","mag":"2892010830"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.9562","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077265672","display_name":"Jennifer Leigh McQuade","orcid":"https://orcid.org/0000-0002-2393-2172","observed_orcids":["https://orcid.org/0000-0002-2393-2172"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Leigh McQuade","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071144743","display_name":"Allison Betof Warner","orcid":"https://orcid.org/0000-0001-6422-2997","observed_orcids":["https://orcid.org/0000-0001-6422-2997"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Betof Warner","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100723471","display_name":"Minmin Li","orcid":"https://orcid.org/0000-0003-4209-3535","observed_orcids":["https://orcid.org/0000-0003-4209-3535"]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Minmin Li","raw_affiliation_strings":["Melanoma Institute of Australia, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute of Australia, Sydney, Australia;","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021765564","display_name":"Jeewon Chon","orcid":"https://orcid.org/0000-0001-9978-6127","observed_orcids":["https://orcid.org/0000-0001-9978-6127"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeewon Chon","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008839819","display_name":"Lauren Elaine Haydu","orcid":"https://orcid.org/0000-0002-6360-0199","observed_orcids":["https://orcid.org/0000-0002-6360-0199"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Elaine Haydu","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076793624","display_name":"Carrie R. Daniel","orcid":"https://orcid.org/0000-0002-6455-9482","observed_orcids":["https://orcid.org/0000-0002-6455-9482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie Daniel-MacDougall","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005194857","display_name":"Kenneth R. Hess","orcid":"https://orcid.org/0000-0003-1377-6070","observed_orcids":["https://orcid.org/0000-0003-1377-6070"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth R. Hess","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Buckner Johnson","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520811","display_name":"Alexander Maxwell Menzies","orcid":"https://orcid.org/0000-0001-5183-7562","observed_orcids":["https://orcid.org/0000-0001-5183-7562"]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alexander M. Menzies","raw_affiliation_strings":["Melanoma Institute Australia, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, Australia;","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040291209","display_name":"Alexander Noor Shoushtari","orcid":"https://orcid.org/0000-0002-8065-4412","observed_orcids":["https://orcid.org/0000-0002-8065-4412"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Noor Shoushtari","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"9562","last_page":"9562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.04410000145435333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8830000162124634},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9919999837875366},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8949999809265137},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.847000002861023},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9829999804496765},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9810000061988831},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5080000162124634},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6190000176429749},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.7459999918937683},{"id":"https://openalex.org/keywords/sex-hormones","display_name":"sex hormones","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9400686025619507},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.7139223217964172},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6738606095314026},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6538529396057129},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6358193159103394},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5847434401512146},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.5156804323196411},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.47125864028930664},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38671889901161194},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23873335123062134},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.10386660695075989}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.9562","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.9562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2945791961","https://openalex.org/W3029688882","https://openalex.org/W3099516709","https://openalex.org/W2786396800","https://openalex.org/W2947580577","https://openalex.org/W2947655659","https://openalex.org/W3115358940","https://openalex.org/W2993774250","https://openalex.org/W4379283664","https://openalex.org/W3159360210"],"abstract_inverted_index":{"9562":[0],"Background:":[1],"Obesity":[2],"has":[3],"recently":[4],"been":[5],"associated":[6,172,202,235,273,321],"with":[7,18,22,38,57,68,173,203,236,242,274,282,298,312,322,329,341],"improved":[8,323],"outcomes":[9,33,58],"in":[10,34,59,92,192,206,218,238,277,306,327,339],"male,":[11,123],"but":[12],"not":[13,171,234,265,320],"female,":[14],"MM":[15,35,65,279,309],"pts":[16,36,66,113,153,280,310],"treated":[17,37,67,281,311],"single-agent":[19,23],"anti-CTLA4":[20,40,69,284],"and":[21,32,82,88,105,161,295],"anti-PD1":[24,42,286,313,331],"immunotherapy.":[25,287],"However,":[26,303],"the":[27,48,193,348,351],"association":[28,49,215,263],"between":[29,85,293],"BMI,":[30,86],"sex,":[31,100,296],"combined":[39,283,330],"+":[41,70,285,332],"is":[43,272],"unknown.":[44],"Methods:":[45],"We":[46],"examined":[47],"of":[50,64,152,159,163,300,308,335],"WHO":[51],"BMI":[52,169,177,222,232,244,271,294,318],"category":[53],"at":[54],"treatment":[55,257],"initiation":[56],"an":[60],"international,":[61],"multi-institutional":[62],"cohort":[63,110],"anti-PD1.":[71],"Kaplan-Meier":[72],"analysis":[73],"was":[74,119,140,170,201,216,233,289,319],"used":[75],"to":[76,248,256],"estimate":[77],"progression":[78],"free":[79],"survival":[80],"(PFS)":[81],"OS.":[83],"Associations":[84],"PFS,":[87],"OS":[89,186,205,276,326],"were":[90,122,154,245,337],"assessed":[91],"Cox":[93],"proportional":[94],"hazard":[95],"models":[96],"adjusted":[97],"for":[98,350],"age,":[99],"AJCC":[101],"8":[102],"stage,":[103],"LDH,":[104,133],"performance":[106],"status.":[107],"Results:":[108],"The":[109],"included":[111],"413":[112],"from":[114],"4":[115],"institutions.":[116],"Median":[117],"age":[118],"57;":[120],"67%":[121],"56%":[124],"had":[125,131,135],"ECOG":[126],"PS":[127],">":[128],"0,":[129],"31%":[130],"elevated":[132],"46%":[134],"BRAFV600":[136],"mutation.":[137],"Clinical":[138],"stage":[139],"9%":[141],"III,":[142],"12%":[143],"M1a,":[144],"20%":[145],"M1b,":[146],"40%":[147],"M1c,":[148],"19%":[149],"M1d.":[150],"75%":[151],"overweight/obese":[155],"(BMI\u226525),":[156],"including":[157],"83%":[158],"males":[160,219,328],"58%":[162],"females.":[164],"In":[165],"multivariable":[166],"(MV)":[167],"models,":[168],"PFS":[174,237,324],"(BMI\u226525":[175,220],"vs.":[176,221],"<":[178,223],"25":[179,224],"HR":[180,225],"1.0,":[181,188],"95%":[182,189,210,227],"CI":[183,190,211,228],"0.7-1.4)":[184],"or":[185,314,325],"(HR":[187,208],"0.6-1.7)":[191],"full":[194],"cohort.":[195],"On":[196],"sex-stratified":[197],"MV":[198],"analysis,":[199],"BMI\u226525":[200],"shorter":[204,275],"females":[207],"2.6,":[209],"1.1-5.8);":[212],"no":[213],"significant":[214,291],"detected":[217],"0.7,":[226],"0.4-1.3;":[229],"pinteraction=":[230],"0.03).":[231],"either":[239],"sex.":[240,268],"Pts":[241],"higher":[243,317,338,342],"more":[246],"likely":[247],"have":[249],"immune":[250],"related":[251],"adverse":[252],"events":[253],"(irAEs)":[254],"leading":[255],"discontinuation":[258],"(p":[259],"=":[260],"0.03);":[261],"this":[262],"did":[264],"differ":[266],"by":[267],"Conclusions:":[269],"Higher":[270],"female":[278],"There":[288],"a":[290],"interaction":[292],"consistent":[297],"analyses":[299],"other":[301],"cohorts.":[302],"unlike":[304],"observations":[305],"cohorts":[307],"anti-CTLA":[315],"alone,":[316],"anti-CTLA4.":[333],"Rates":[334],"irAEs":[336],"patients":[340],"BMI.":[343],"Further":[344],"studies":[345],"should":[346],"examine":[347],"basis":[349],"observed":[352],"associations.":[353]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-09-27T00:00:00"}